73 related articles for article (PubMed ID: 10716325)
41. [3H-colchicine accumulation in a mixed culture of colcemide-resistant and -sensitive cells].
Boĭtsova LIu; Mittel'man LA; Chaĭlakhian LM
Tsitologiia; 1983 Apr; 25(4):479-83. PubMed ID: 6879718
[TBL] [Abstract][Full Text] [Related]
42. Optical detection of the structural properties of tumor tissue generated by xenografting of drug-sensitive and drug-resistant cancer cells using partial wave spectroscopy (PWS).
Adhikari P; Nagesh PKB; Alharthi F; Chauhan SC; Jaggi M; Yallapu MM; Pradhan P
Biomed Opt Express; 2019 Dec; 10(12):6422-6431. PubMed ID: 31853408
[TBL] [Abstract][Full Text] [Related]
43. CHC and surgery: when is stopping safe?
Schulman S
Blood; 2024 Jan; 143(1):9-10. PubMed ID: 38175679
[No Abstract] [Full Text] [Related]
44. Radiosynthesis, Preclinical, and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds.
Shegani A; Kealey S; Luzi F; Basagni F; Machado JDM; Ekici SD; Ferocino A; Gee AD; Bongarzone S
Chem Rev; 2023 Jan; 123(1):105-229. PubMed ID: 36399832
[TBL] [Abstract][Full Text] [Related]
45. NRM 2021 Abstract Booklet.
J Cereb Blood Flow Metab; 2021 Dec; 41(1_suppl):11-309. PubMed ID: 34905986
[No Abstract] [Full Text] [Related]
46. Preliminary Evaluations of [
Lindberg A; Mossine AV; Aliaga A; Hopewell R; Massarweh G; Rosa-Neto P; Shao X; Bernard-Gauthier V; Scott PJH; Vasdev N
Front Neurosci; 2021; 15():725873. PubMed ID: 34566568
[TBL] [Abstract][Full Text] [Related]
47. Radiosynthesis and in Vivo Evaluation of [
Kumar JSD; Solingapuram Sai KK; Prabhakaran J; Oufkir HR; Ramanathan G; Whitlow CT; Dileep H; Mintz A; Mann JJ
J Med Chem; 2018 Mar; 61(5):2118-2123. PubMed ID: 29457976
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and In Vivo Imaging of N-(3-[
Petroni D; Bartoli A; Rapposelli S; Digiacomo M; Burchielli S; Nesi G; Lapucci A; Pardini S; Fucci S; Macchia M; Salvadori PA; Menichetti L
Mol Imaging Biol; 2016 Dec; 18(6):916-923. PubMed ID: 27234445
[TBL] [Abstract][Full Text] [Related]
49. Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.
Syvänen S; Eriksson J
ACS Chem Neurosci; 2013 Feb; 4(2):225-37. PubMed ID: 23421673
[TBL] [Abstract][Full Text] [Related]
50. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.
Amiri-Kordestani L; Basseville A; Kurdziel K; Fojo AT; Bates SE
Drug Resist Updat; 2012; 15(1-2):50-61. PubMed ID: 22464282
[TBL] [Abstract][Full Text] [Related]
51. PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.
Mairinger S; Erker T; Muller M; Langer O
Curr Drug Metab; 2011 Oct; 12(8):774-92. PubMed ID: 21434859
[TBL] [Abstract][Full Text] [Related]
52. Imaging and cancer: a review.
Fass L
Mol Oncol; 2008 Aug; 2(2):115-52. PubMed ID: 19383333
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function.
Lazarova N; Zoghbi SS; Hong J; Seneca N; Tuan E; Gladding RL; Liow JS; Taku A; Innis RB; Pike VW
J Med Chem; 2008 Oct; 51(19):6034-43. PubMed ID: 18783208
[TBL] [Abstract][Full Text] [Related]
54. Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.
Elsinga PH; Hendrikse NH; Bart J; van Waarde A; Vaalburg W
Mol Imaging Biol; 2005; 7(1):37-44. PubMed ID: 15912274
[TBL] [Abstract][Full Text] [Related]
55. Positron emission tomography (PET): expanding the horizons of oncology drug development.
Hammond LA; Denis L; Salman U; Jerabek P; Thomas CR; Kuhn JG
Invest New Drugs; 2003 Aug; 21(3):309-40. PubMed ID: 14578681
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of 11C-colchicine for PET imaging of multiple drug resistance.
Levchenko A; Mehta BM; Lee JB; Humm JL; Augensen F; Squire O; Kothari PJ; Finn RD; Leonard EF; Larson SM
J Nucl Med; 2000 Mar; 41(3):493-501. PubMed ID: 10716325
[TBL] [Abstract][Full Text] [Related]
57. In vivo uptake of carbon-14-colchicine for identification of tumor multidrug resistance.
Mehta BM; Rosa E; Biedler JL; Larson SM
J Nucl Med; 1994 Jul; 35(7):1179-84. PubMed ID: 8014680
[TBL] [Abstract][Full Text] [Related]
58. Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET.
Elsinga PH; Franssen EJ; Hendrikse NH; Fluks L; Weemaes AM; van der Graaf WT; de Vries EG; Visser GM; Vaalburg W
J Nucl Med; 1996 Sep; 37(9):1571-5. PubMed ID: 8790221
[TBL] [Abstract][Full Text] [Related]
59. In-vivo identification of tumor multidrug resistance with 3H-colchicine [corrected].
Mehta BM; Rosa E; Fissekis JD; Bading JR; Biedler JL; Larson SM
J Nucl Med; 1992 Jul; 33(7):1373-7. PubMed ID: 1613580
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
